Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientif... (Sam Brown Communications 608-850-474...)

(Date:11/20/2008)..., Nov. 20 Clinical data from a pro... Annual Veith Symposium shows DVT,treatment with ...chus,Vascular, Inc. (Santa Clara, CA) successfull...out 20 minutes. , This technique, called is...blood flow more quickly and safely than current ca...

(Date:11/19/2008)..., Study did not achieve statistical significance...stCall/ -- Pharmos Corporation (Nasdaq: PARS ) t...trial of its topical NanoEmulsion (NE) drug delive...nolamine. , , The multi-center, randomized,...d the safety and efficacy of the Company,s 3% Dicl...

(Date:11/18/2008)...November 19 NeuroDiscove...ce provider and drug development Company,and Sos...4565), a leading,international biopharmaceutical ...esenting further pivotal pre-clinical efficacy dat... a potential therapy for neuropathic pain and has,...

(Date:11/18/2008)...ed study will enroll newly diagnosed, elderly AML ...wswire/ -- Celator Pharmaceuticals today announced...omized Phase 2 clinical study of CPX-351 (Cytarabi...th newly diagnosed acute myeloid leukemia (AML). ,...eldman, MD at the Weill Medical College of Cornel...

Breaking Medicine Technology:Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 2 Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 3 Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2 Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2 Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 3 Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 2 Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 3 Quigley Anti Viral Compound QR448 28a 29 Successfully Prevents Transmission of Infectious Bronchitis in Chickens 3068 1 Quigley Anti Viral Compound QR448 28a 29 Successfully Prevents Transmission of Infectious Bronchitis in Chickens 3068 2 Quigley Anti Viral Compound QR448 28a 29 Successfully Prevents Transmission of Infectious Bronchitis in Chickens 3068 3 Quigley Anti Viral Compound QR448 28a 29 Successfully Prevents Transmission of Infectious Bronchitis in Chickens 3068 4 ProSource 2 0 Offers Value Savings for Lab Supplies 7714 1 ProSource 2 0 Offers Value Savings for Lab Supplies 7714 2 Why some primates but not humans can live with immunodeficiency viruses and not progress to AIDS 4907 1 Why some primates but not humans can live with immunodeficiency viruses and not progress to AIDS 4907 2 Why some primates but not humans can live with immunodeficiency viruses and not progress to AIDS 4907 3 Why some primates but not humans can live with immunodeficiency viruses and not progress to AIDS 4907 4 Sir David Lane honored with Royal Gold Medal by Royal Society of Edinburgh 4902 1

[0] Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series [0] Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream [4] Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting [0] Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351

...BUSINESS WIRE)--Jun 6, 2007 - Metabasis Therapeuti...y focused on the,discovery, development and commer...tabolic and liver diseases by applying unique,capa...s, announced,today that two posters were presented... Toronto, Canada., Both posters provide data on MB...

...ng ROX-888 Required Significantly Less Morphine Af...le NDA In 2008, MENLO PARK, CA (June 6, 2007) &nda... novel intranasal,analgesic, rapidly and effective...ho had undergone major abdominal surgery in,a Phas...and final Phase 3 clinical study," said,ROXRO PHAR...

Other Medicine Technology:Metabasis Therapeutics Presents Results of Preclinical Studies for,MB07811, Its Novel Product Candidate for the Treatment of,Hyperlipidemia, at the Endocrine Society's Annual Meeting 2 Metabasis Therapeutics Presents Results of Preclinical Studies for,MB07811, Its Novel Product Candidate for the Treatment of,Hyperlipidemia, at the Endocrine Society's Annual Meeting 3 Metabasis Therapeutics Presents Results of Preclinical Studies for,MB07811, Its Novel Product Candidate for the Treatment of,Hyperlipidemia, at the Endocrine Society's Annual Meeting 4 Roxro Pharma’s Novel Intranasal Pain Reliever Effective, Well,Tolerated in Phase 3 Study 2

Metabasis Therapeutics Presents Results of Preclinical Studies for,MB07811, Its Novel Product Candidate for the Treatment of,Hyperlipidemia, at the Endocrine Society's Annual Meeting Roxro Pharma’s Novel Intranasal Pain Reliever Effective, Well,Tolerated in Phase 3 Study

(Date:11/21/2008)...apies for preterm labor , , FRIDAY, Nov....und the switch that activates the uterine muscles ...may lead to therapies for preterm labor. , The...IP on the surface of these uterine muscle cells, k..., But researchers from Dartmouth Medical Schoo...

(Date:11/21/2008)...ers to be held on January 8, 2009 , , TORON...ernational Inc. ("MedEmerg") (OTCBB: MDER), one of...nounced today that it has obtained an interim orde...rning its previously announced plan of arrangement...Group Inc. ("AIM") will acquire all of MedEmerg,s ...

(Date:11/21/2008)...niversity of Texas Health Science Center at Housto...n Aging Studies (TEXAS), to promote geriatrics tra...ion award from the Donald W. Reynolds Foundation a...llow us to teach geriatric medicine principles to ...racticing physicians. With the reach of Lyndon B. ...

(Date:11/21/2008)...Newswire-FirstCall/ -- Heska Corporation,(Nasdaq:...ew York Society of,Security Analysts, 12th Annual...ber 2, 2008 at 1177 Avenue of the Americas, 2nd Fl...d to begin at 9:35 a.m. Eastern Time (7:35 a.m.,M...st and for two weeks,following the presentation t...

Breaking Medicine News(10 mins):Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 2 Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 3 Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 2 Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 3 Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 4

[0] Scientists ID Uterine Muscle Switch for Contractions [0] Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc.[0] UT Houston launches geriatric training with $3.25 million in grant, matching funds [0] Heska to Present at New York Society of Security Analysts' 12th Annual Biotech and Specialty Pharma Conference

...tudy has revealed that anti-depressants like Fluox... damage upon the human skeleton.// The Norwegian U...rcher Bjorn I. Gustafsson has revealed that anti-d...ty of bone building cells, while raising the produ...

...rom University of North Carolina have identified a...ng the activity of Tumor// suppressor protein. Tum...ng the integrity of cell and prevents the cell fro...h of cell. Ack1 is found to be a growth promoting ...

... has lifted the ban on the import of poultry produ... of bird flu strain //for the second time in a mon...n follows identifying that both the isolated virus... is found to be a non-infectious and less pathogen...

...ey has revealed that about 6 out of 10 parents of ...ctivity Disorder (ADHD) are not getting// enough s...launched by the drugs firm Eli Lilly and National ...rmation and Support Service (ADDISS) is to help pa...

Other Medicine News:Health News:Gene responsible for developing prostate cancer identified 2

Skeleton May Sustain Damage Due To Use Of Anti-Depressants Gene responsible for developing prostate cancer identified Ban on exports of poultry products from British Columbia lifted Parents Of ADHD Children Suffering Sleep Problems

...y and lower cost per test for the clinical lab. ,...ecks in the busy clinical lab... the new StatSpin ...fuge spins standard 5 mL blood collection tubes in...r plasma equal to 10-15 minute runs in larger, mor...

...stem for performing fast, clean, safe and accurate...em is microprocessor controlled to automatically s...e. At the end of the cycle, the urine sediment is ...roscopic analysis.,The CenSlide Urinalysis Sy...

Used to provide drainage of urine from the bladder. All-silicone construction provides maximum softness and biocompatibility for enhanced patient comfort. Supplied sterile in peel-open packages. Inte

Used for temporary internal drainage from the ureteropelvic junction to the bladder. Supplied sterile in peel-open packages. Intended for one-time use. CAUTION: Periodic evaluation is advised; polyur

Medicine Products:

StatSpin Express 2 CenSlide 2000 system Silicone Foley Double Pigtail Stent Sets - Sof-Flex®

Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientif...(Sam Brown Communications 608-850-474...),Health